Product Details
Additional Information
| Product Name | Benlysta (belimumab) for Injection, 400 mg, Vial |
| Manufacturer | -- |
| Generic/Active Ingredient | Belimumab |
| Route of Administration | Intravenous |
| Dose Form | Parenteral preparations |
| Strength | 400 mg |
| Container Type | Vial |
| Mechanism of Action | Belimumab binds BLyS and blocks its interaction with B cells, which reduces survival of autoreactive B cells and lowers formation of antibody-producing plasma cells. |
| Application | Immunosuppressive Monoclonal Antibody |
| Side Effects | Adverse events include infusion reactions, hypersensitivity, infections, gastrointestinal upset, headache, rash, psychiatric effects, and injection site reactions. |
| Storage | Avoid exposure to heat. Discard product if it contains particulate matter, is cloudy, or discolored. Discard product if stored at room temperature for more than 12 hours. Discard unused portion. Do not store for later use. Do not freeze. Protect from direct sunlight. Protect from light. Refrigerate at 36°F to 46°F. Store diluted product in accordance Store in original package until time of use. Store reconstituted product in accordance |
This description is for informational purposes only and is not clinical advice.
Frequently Asked Questions (FAQs)
The cost of BENLYSTA PR 400MG PF SPD is $available for registerd members only
BENLYSTA PR 400MG PF SPD is manufactured by --.
You can purchase BENLYSTA PR 400MG PF SPD on our website at https://supplies.pipelinemedical.com/product/detail/benlysta-pr-400mg-pf-spd-640929